We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Tissue-Imaging Technology Enables Real-Time Diagnostics

By LabMedica International staff writers
Posted on 04 Jul 2018
A new microscope system can image living tissue in real time and in molecular detail, without any chemicals or dyes. More...
The system is called simultaneous label-free autofluorescence multi-harmonic microscopy (SLAM).

The system uses precisely tailored pulses of light to simultaneously image with multiple wavelengths. This enables scientists to study concurrent processes within cells and tissue, and could give those studying cancer a new tool for tracking tumor progression and physicians new technology for tissue pathology and diagnostics.

Scientists at the University of Illinois at Urbana-Champaign, Urbana, IL, USA) designed an optical imaging platform that performs simultaneous label-free autofluorescence-multiharmonic (SLAM) microscopy, featuring fast epi-detection of nicotinamide adenine dinucleotide (NADH) from three-photon autofluorescence (3PAF) and simultaneous, and efficient acquisition of autofluorescence (FAD) from two-photon autofluorescence (2PAF), combined with non-centrosymmetric structures from second-harmonic generation (SHG) and interfacial features from third-harmonic generation (THG).

The team saw that the cells near the mammary tumors in rats had differences in metabolism and morphology, indicating that the cells had been recruited by the cancer. In addition, they observed surrounding tissues creating infrastructure to support the tumor, such as collagen and blood vessels. They also saw communication between the tumor cells and the surrounding cells in the form of vesicles, tiny transport packages released by cells and absorbed by other cells. The authors concluded that they had demonstrated the versatility and efficiency of SLAM microscopy for tracking cellular events in vivo, and are a major enabling advance in label-free intravital microscopy (IVM).

Stephen A. Boppart, MD, PhD, a professor and head of the Biophotonics Imaging Laboratory, and senior author of the study, said, “With advances in microscopy techniques such as ours, we hope to change the way we detect, visualize and monitor diseases that will lead to better diagnosis, treatments and outcomes.” The study was published on May 29, 2018, in the journal Nature Communications.

Related Links:
University of Illinois at Urbana-Champaign


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.